Computer-aided detection (CAD) is known to boost radiologist performance in the detection of lung nodules, and radiologists certainly need the help. But despite a decade of fine-tuning and some powerful new capabilities, CAD systems haven’t found a place in daily practice at most imaging facilities.  {read more here}

Quantitative values of simultaneous F-18 choline PET and diffusion-weighted imaging (DWI) do not correlate in the assessment of intermediate prostate cancer—perhaps because the measurements characterize different tumor biology, according to a study published last month in PLOS ONE.  {read more here}

PET/CT can accurately detect recurrent thyroid disease not demonstrated by radioiodine scans, according to a presentation that will be given in September at the Royal College of Radiologists Annual Scientific Meeting, which will be held in London, UK.  {read more here}

Neuraceq (F-18 florbetaben) became available for commercial use on August 1 and has gone into action for clinical PET imaging of beta-amyloid in the brain at WVU Healthcare in Morgantown, W.Va., Piramal Imaging announced today. {read more here}